Dr. Idan Roifman, MD
Claim this profileSunnybrook Health Sciences Centre
Studies Aortic Valve Stenosis
Studies Pneumothorax
3 reported clinical trials
4 drugs studied
Affiliated Hospitals
Clinical Trials Idan Roifman, MD is currently running
TAVR
for Aortic Stenosis
Obtain safety and effectiveness data to support indication expansion for the Medtronic TAVR System to include patients with moderate, AS.
Recruiting1 award N/A3 criteria
Lung Ultrasound vs Chest X-ray
for Collapsed Lung
Sunnybrook Health Sciences Center annually provides assistance to approximately 600 cardiac surgeries and 1500 trauma patients, many of whom require chest tubes to prevent blood and fluids from accumulating in the pleural cavities surrounding the heart. During the removal of chest tubes, there is a risk of air leaking into these cavities, leading to pneumothorax, a critical condition occurring in approximately 5-26% of cases, associated with increased complications and mortality. Currently, the diagnosis of pneumothorax is primarily based on chest X-rays (CXR), despite their limitations and low reliability. As an alternative method, lung ultrasound (LUS) offers several advantages: it is safer, less expensive, and less painful for patients compared to CXR. However, there is a lack of comparative data on the accuracy and interrater reliability of these two diagnostic approaches after chest tube removal. This study aims to evaluate the accuracy of lung ultrasound performed by medical trainees in diagnosing pneumothorax in cardiac and trauma patients. By comparing LUS to CXR, the investigators seek to determine if LUS provides a more reliable and precise diagnosis. This study has the potential to enhance patient care by establishing a more effective and accessible method for diagnosing pneumothorax post-chest tube removal.
Recruiting1 award N/A2 criteria
More about Idan Roifman, MD
Clinical Trial Related2 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Idan Roifman, MD has experience with
- Evolut FX TAVR System
- Medtronic Evolut PRO+ TAVR System
- Lung Ultrasound
- Tideglusib
Breakdown of trials Idan Roifman, MD has run
Aortic Valve Stenosis
Collapsed Lung
Uraemic Cardiomyopathy
Right Ventricular Cardiomyopathy
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Idan Roifman, MD specialize in?
Idan Roifman, MD focuses on Aortic Valve Stenosis and Pneumothorax. In particular, much of their work with Aortic Valve Stenosis has involved treating patients, or patients who are undergoing treatment.
Is Idan Roifman, MD currently recruiting for clinical trials?
Yes, Idan Roifman, MD is currently recruiting for 2 clinical trials in Toronto Ontario. If you're interested in participating, you should apply.
Are there any treatments that Idan Roifman, MD has studied deeply?
Yes, Idan Roifman, MD has studied treatments such as Evolut FX TAVR System, Medtronic Evolut PRO+ TAVR System, Lung Ultrasound.
What is the best way to schedule an appointment with Idan Roifman, MD?
Apply for one of the trials that Idan Roifman, MD is conducting.
What is the office address of Idan Roifman, MD?
The office of Idan Roifman, MD is located at: Sunnybrook Health Sciences Centre, Toronto, Ontario M4N 3M5 Canada. This is the address for their practice at the Sunnybrook Health Sciences Centre.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.